NUVISAN The Science CRO
Alexander Aslanidis, PhD, currently serves as a Business Development Manager at NUVISAN The Science CRO, focusing on promoting preclinical drug discovery services for biopharmaceutical companies. Prior experience includes roles as Business Development Manager and Sales Manager at JANVIER LABS, where Alexander specialized in preclinical research models in immunology and oncology, and as an Account Manager at Eurogentec, promoting genomics and proteomics products. Alexander's early career involved postdoctoral research at Uniklinik Köln, investigating retinal diseases, and multiple research assistant positions, including a focus on genetics and immune responses in retinal degenerative conditions. Academic qualifications include a PhD in Molecular Medicine from the University of Cologne and advanced degrees in Biology from the University of Regensburg.
NUVISAN The Science CRO
1 followers
Founded in Europe with more than 40 years of experience, NUVISAN is a fully integrated contract research and development, and manufacturing organization (CRO/CDMO) that offers unique, high-quality, and tailored integrated solutions along the drug discovery and development value chain. With more than 1.000 employees distributed over six locations in Germany and France including our drug discovery hub in Berlin as well as with local experts situated in Latin America, NUVISAN is pleased to offer the following portfolio of services: • Drug discovery & research - Discovery pharmacology - Discovery bioscience - Screening - Life science chemistry - Translation research - Digital life science - Toxicology - DMPK • Non-clinical studies • Pharmaceutical analysis • Topical formulation development • Chemical development with GMP manufacturing (3-10kg) • Bioanalytical labs • GMP manufacturing (up to 50Kg) • Clinical trial supplies • Phase 1 and 2 clinical studies and beyond Our services can be provided as stand-alone or integrated solutions and can be customized to your project. Email us at hello@nuvisan.com for more.